Dante Genomics, a global leader in AI-driven genomic analysis, has expanded into Dante Omics AI to reflect its evolution into ...

Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular ...

Inflammatory bowel diseases (IBDs), which include ulcerative colitis (UC) and Crohn’s disease (CD), are chronic conditions ...

While it is currently predicted that less than 1% of bacterial organisms can be cultured in the lab, meta-omics (particularly metagenomics) has been the most popular microbiology methodology for ...

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast ...

Mayo Clinic researchers have developed OmicsFootPrint, an AI tool that transforms complex biological data into intuitive ...

By Dr. Sanchari Sinha Dutta, Ph.D. A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets ...

Multi-omics research is revolutionizing the field of tropical disease by offering a comprehensive approach to understanding ...

Intelligent Omics' Dr Rob Grundy discusses how combining AI with big data can lead to better drug discovery processes and that partnerships can help more organisations leverage cutting-edge tools.

Latch is partnering with multi-omics providers like AtlasXomics to re-rewrite their NGS pipelines with GPUs, achieving to up ...

Building on years of innovation—from the Dante Labs Genome to the Avanti Platform—Dante Omics AI introduces fully integrated solutions designed for diagnostics, biopharma and longevity.